Quarterly report pursuant to Section 13 or 15(d)

Revenue (Details Narrative)

v3.21.2
Revenue (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 561,000 $ 1,134,000 $ 6,635,000 $ 7,673,000
Treatment Services [Member]        
Disaggregation of Revenue [Line Items]        
Revenue recognized $ 1,286,000   $ 1,286,000  
Revenue information related to variable consideration constraint     The Company’s contracts generally do not give rise to variable consideration. However, during the three and nine months ended September 30, 2021, the Company recognized approximately $1,286,000 in revenue from a request for equitable adjustment (“REA”) under one of the Company’s Treatment Services contracts that resulted in cumulative catch-up adjustment in the transaction price that had been constrained in prior periods.